The RNA Society is celebrating its 30th Annual Meeting in San Diego, and we are excited to be part of it as an exhibitor! Dr. John Randolph will be representing Synoligo and connecting with the RNA research community to share our oligonucleotide manufacturing capabilities. We look forward to seeing you there!
Read more »
Synoligo is proud to support TIDES USA, one of North America’s premier conferences for oligonucleotide and peptide therapeutics. This event aligns with our core belief in the power of collaboration and knowledge sharing to drive innovation, from early discovery to clinical application. Visit us at booth #313!
Synoligo is committed to staying at the forefront of RNA innovation. That’s why we’re proud to sponsor the 4th Circular & saRNA Therapeutics Summit. Events like this are vital for sharing ideas and driving forward the next generation of RNA therapeutics. Mark your calendar!
Synoligo is excited to announce our sponsorship of the 4th Annual Novel Conjugates Summit next month. Our team is prepared to engage with industry experts and showcase how our oligo conjugation services can help drive innovation in targeted cancer therapies. Join us! https://lnkd.in/giCX9Fgn
Synoligo is proud to sponsor the 10th Annual OPT Congress, where innovation in oligonucleotide therapies takes center stage! This year’s program highlights emerging oligo modalities and cutting-edge approaches to designing targeted treatments. We hope to see you there!
This year, we’re back as a sponsor for the RNA Leaders Europe Congress! Our team is eager to connect with researchers and industry leaders spanning the entire RNA spectrum, including oligo-based RNA, next-gen RNA, and mRNA vaccines and therapeutics. Let’s drive RNA innovation together!
Looking ahead to January 2025, Synoligo is proud to sponsor our first event, the 6th Annual RNAi-Based Therapeutics Summit! Our team is eager to connect with leading experts and delve into advancements in chemical modifications for the next-generation.
What an incredible year it has been! Synoligo is closing 2024 with one final event, the 5th Annual Genome Editing Therapeutic Summit. We are looking forward to explore the latest advancements in cutting-edge therapies and precision #genome editing techniques that drive #innovation in drug development for #genetic diseases.
Morrisville, North Carolina, October 29, 2024 — Synoligo Biotechnologies Inc., a Contract Research and Development Organization (CRDO) based in Research Triangle Park, announced the expansion of its production capabilities with the addition of a new 5,000 square foot facility dedicated to high-throughput custom oligonucleotide synthesis. This expansion marks a significant milestone in Synoligo’s rapid growth […]
Synoligo is pleased to continue our sponsorship of the @Oligonucleotide Therapeutics Society meeting in Montreal this year. This meeting is a great opportunity to explore the progress of #oligonucleotides from basic research to therapeutic development. Save the date! https://www.2024oligomeeting.com/
Another eventful week ahead for the Synoligo team! We’re excited to attend the Genome Engineering: #CRISPR Frontiers Meeting from August 27th-31st. We look forward to exploring the latest advancements in #genome engineering and discovering new ways we can contribute! #cshlcrispr24 #gRNA
The Oligonucleotides CMC & Analytical Development Summit is returning for its 3rd year on August 27-29. Over 100 industry leaders will come together to discuss regulatory requirements, CMC, and analytical strategies to ensure the scalability and manufacturability of high-quality products. Synoligo is excited to sponsor and participate in these vital discussions.
Synoligo will be sponsoring RNA Leaders US Congress, taking place next month. Get ready for inspiring talks, networking opportunities and so much more. See you there! https://informaconnect.com/rna-leaders-usa/#rnaleaders #mRNA #RNAi #biopharma #rnatherapeutics
Next month, our team will be joining other industry experts and key opinion leaders at RNA Therapeutic Concept to Clinic in Worcester, MA. Get more info here https://www.umassmed.edu/RNATx/ #RNATx2024 #rnatherapeutics #rnaediting #oligonucleotide #biopharma
Today marks the first annual retreat for the UNC RNA Discovery Center. As a company committed to supporting our academic community in driving scientific discovery through research, we are honored to be the main sponsor for this event. Thank you for having us!
We will back in Boston next month for one of the biggest events of the year, #TIDESUSA. We look forward to connect with experts in the #oligonucleotide & peptide therapeutic field. Check out the agenda https://lnkd.in/gaGDpUeJ #biopharma #rnatherapeutics
Our team will be attending the Oligonucleotide Therapeutics Xchange on Feb 28th in San Diego. We look forward to learning more about the current challenges and discoveries in the field. Join us at the networking hour! Check out the agenda here: https://lnkd.in/eXpNsFQd
Synoligo is thrilled to sponsor the 9th annual OPT Congress Conference! We can’t wait to connect with the RNA community. For more info: https://lnkd.in/esJDw5s
Exciting news alert! Synoligo is ecstatic to announce our first collaboration of the year. We’re honored to join forces with N=1 Collaborative, an internationally acclaimed organization, on a mission to connect researchers, clinicians, physicians, patients, and drug developers worldwide under a standardized framework for individualized medicine. Their current initiative is to bring together experts in ASOs, […]
We are proud to sponsor the 3rd #RNA Leaders Europe! Join us in Basel March 13-14th to connect with industry leaders from around the globe. More info here: https://lnkd.in/dzfJxf-z
The industry’s leading event in Europe for #oligonucleotides, peptides, #mRNA and drug delivery will be taking place next month in Germany. We are looking forward to attending TIDES EUROPE to learn more about challenges, trends, and technologies across the therapeutic area.
Get access to technical content, promotions, upcoming events and press release.
